Lydia Fancher
Pharmacist
601 E Rollins St, Orlando
Florida, 32803-1248
407-303-5600 Lydia Fancher is a pharmacist in Orlando, Florida. Patients can reach her at 601 E Rollins St, Orlando or contact her on 407-303-5600. Active license number of Lydia Fancher is PS41331 for Pharmacist in Florida.
Lydia Fancher is
Complete Profile:
Lydia Fancher speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
| Name: | Lydia Fancher |
| Specialization: | Pharmacist |
| Credentials: | PHARMD |
| Gender: | Female |
| Location: | 601 E Rollins St, Orlando,
Florida, 32803-1248 |
| Phone: | 407-303-5600 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Lydia Fancher are as mentioned below.
| NPI Number: | 1386593382 |
| NPI Enumeration Date: | 23 Jan, 2026 |
| NPI Last Update On: | 23 Jan, 2026 |
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Lydia Fancher are as mentioned below.
| Specialization | License Number | State | Status | |
| Pharmacist | PS41331 | Florida | Primary | |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 1303 W Yale St,
Orlando, Florida |
| Zip: | 32804-5636 |
| Phone Number: | -- |
Patients can reach Lydia Fancher at
601 E Rollins St, Orlando, Florida or can
call on phone at 407-303-5600.
Comments/ Reviews:
Read all the reviews posted for Lydia Fancher below. You may also share your own experience with Lydia Fancher. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 March, 2026.